18 October 2017

GSK Luxembourg SA recognized as “Recommended Firm” by IFLR1000

IFLR1000 – the Guide to the World’s Leading Financial Law Firms has nominated the leading law firms and lawyers in 2018. Once again GSK Stockmann in Luxembourg is one of the recognized law firms this year.

GSK was again awarded in the “Investment funds” section (Tier 4). In the area of “Financial and Corporate” GSK Luxembourg was able to improve and is now ranked in Tier 3. Moreover GSK Luxembourg SA received the award “Recommended Firm 2018”.

Lawyers were also honored by IFLR1000. Thus, Dr. Philipp Mößner was named “Leading Lawyer – Rising Star” and was ranked in the Banking/Finance and Capital Markets divisions. Dr. Marcus Peter was awarded as “Leading Lawyer – Highly Regarded” and was mentioned in the practice areas Corporate/M&A and Investment Funds as well as in the sector Investment Management. Furthermore, Arne Bolch was ranked in the “Investment Funds” area. 

The general client feedback was very positive: 

  • “Very good quality of service” (Financial services regulatory)
  • “I appreciate that the working relationship is human and tailored to the customer personally. The work provided is of a high quality and worth the money. If any problems arise, the client is advised sufficiently in advance.” (Investment funds)
  • “Very up to the point, swift advice in a complex transaction involving Luxembourg law.” (M&A)


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Dr. Marcus Peter, LL.M. eur.


+352 271802-50


Dr. Philipp Mössner, LL.M. (McGill)


+352 271802-40


© GSK Stockmann 2024